Kozak sequence libraries for systematically characterizing transgenes across expression levels

Nucleic Acids Res. 2026 Jul 17;54(14):gkag728. doi: 10.1093/nar/gkag728.

Abstract

Typical mammalian overexpression systems test protein sequence variants with little control over expression levels and steady-state protein abundances, hindering interpretations of how protein sequence and expression converge to yield phenotypic outcomes. We explored the translation initiation sequence, commonly referred to as the Kozak sequence, as a means to systematically modulate protein steady-state abundance and cellular function. We performed sort-seq on a randomized library of the 6 nt preceding the start codon, amounting to 4042 sequences, with a single sequence integrated at a shared genomic integration site in each HEK 293T cell. Calibrating the scores revealed a ∼100-fold range of protein steady-state abundances possible through manipulation of the Kozak sequence. We identified human germline variants with predicted expression-reducing Kozak substitutions in disease-associated genes. Modulating the cell surface abundance of the host cell receptor ACE2 controlled the rate at which those cells became infected by SARS-like coronavirus spike pseudotyped particles. We demonstrated the potential of the approach by simultaneously testing Kozak libraries with a small panel of coding variants for ACE2 and STIM1. This approach lays the methodological groundwork for linking the causal relationships between protein sequence, abundance, and functional outcome.

MeSH terms

  • Angiotensin-Converting Enzyme 2 / genetics
  • Codon, Initiator*
  • Gene Library*
  • HEK293 Cells
  • Humans
  • Peptide Chain Initiation, Translational*
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus / genetics
  • Spike Glycoprotein, Coronavirus / metabolism
  • Transgenes*

Substances

  • Angiotensin-Converting Enzyme 2
  • ACE2 protein, human
  • Codon, Initiator
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2